Voltar
Artigo Revisado por pares
BIBTEX RIS

ID: 335853 Initial Clinical Safety and Feasibility from RESET-RA Study: Novel Neuroimmune Modulation Device for Rheumatoid Arthritis

2024; Elsevier BV; Volume: 27; Issue: 7 Linguagem: Inglês

10.1016/j.neurom.2024.06.340

ISSN

1525-1403

Autores

David Chernoff, Daniel Peterson, Mark Van Poppel, Warren Boling, Perry M. Santos, Jason M. Schwalb, Howard M. Eisenberg, Ashesh D. Mehta, Heather Spader, James Botros, Frank D. Vrionis, Andrew L. Ko, P. David Adelson, Bradley Lega, Peter E. Konrad, R. Mark Richardson,

Tópico(s)

Rheumatoid Arthritis Research and Therapies

Referência(s)